rhGAD65
Showing 1 - 9 of 9
Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)
Recruiting
- Diabetes Mellitus, Type 1
- GAD-alum (Diamyd) 40 μg/mL
-
Linköping, SwedenKliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022
Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)
Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)
Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)
Completed
- Diabetes Mellitus, Type 1
- GAD-Alum
- Vitamin D
-
Linköping, SwedenLinköping University
Apr 15, 2020
Diabetes, Type 1 Trial in Sweden (GAD-Alum (Diamyd) 20 µg, GAD-Alum (Diamyd) 20 µg X 2, Vitamin D)
Completed
- Diabetes Mellitus, Type 1
- GAD-Alum (Diamyd) 20 µg
- +3 more
-
Halmstad, Sweden
- +9 more
Aug 22, 2017
Type 1 Diabetes Trial in United States (rhGAD65, Placebo)
Terminated
- Type 1 Diabetes Mellitus
- rhGAD65
- Placebo
-
Tucson, Arizona
- +42 more
Oct 9, 2012
Type 1 Diabetes Trial in Worldwide (rhGAD65, Placebo)
Terminated
- Type 1 Diabetes Mellitus
- rhGAD65
- Placebo
-
Helsinki, Finland
- +69 more
Oct 7, 2011
Latent Autoimmune Diabetes in Adult (LADA) Trial in Sweden (rhGAD65 formulated in Alhydrogel® (Diamyd®))
Completed
- Latent Autoimmune Diabetes in Adult (LADA)
- rhGAD65 formulated in Alhydrogel® (Diamyd®)
-
Alingsås, Sweden
- +16 more
Jun 9, 2011
Type 1 Diabetes Trial in Sweden (rhGAD65 formulated in Alhydrogel® (Diamyd®))
Completed
- Type 1 Diabetes
- rhGAD65 formulated in Alhydrogel® (Diamyd®)
-
Borås, Sweden
- +7 more
Jan 29, 2008